Privia Health Group, Inc.
PRVANASDAQHealthcare● Active
$21.55
$-0.08(-0.37%)
Market Cap$2.7B
P/E Ratio—
52W High$26.51
52W Low$18.77
Privia Health Group, Inc. (PRVA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PRVA · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
$0.02
Est. $0.08 · -75.0%
Revenue
$0.60B
Est. $0.56B · +7.6%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
PRVA reports quarterly as a NASDAQ-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.08 | — | — | — | $0.60B | — |
| ▼ Q2 FY2026 | May 7, 2026 | $0.08 | $0.02 | -75.0% | $0.60B | $0.56B | +7.6% |
| ▲ Q1 FY2026 | Feb 26, 2026 | $0.04 | $0.07 | +75.0% | $0.54B | $0.52B | +4.8% |
| ▼ Q4 FY2025 | Nov 6, 2025 | $0.06 | $0.05 | -16.7% | $0.58B | $0.52B | +12.3% |
| ▼ Q3 FY2025 | Aug 7, 2025 | $0.05 | $0.02 | -60.0% | $0.52B | $0.49B | +7.3% |
| ▼ Q2 FY2025 | May 8, 2025 | $0.06 | $0.03 | -50.0% | $0.48B | $0.46B | +4.7% |
| ▼ Q1 FY2025 | Feb 27, 2025 | $0.05 | $0.03 | -40.0% | $0.46B | $0.48B | -4.1% |
| ▼ Q4 FY2024 | Nov 7, 2024 | $0.05 | $0.03 | -40.0% | $0.44B | $0.42B | +4.1% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.08
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Miss
EPS Actual
$0.02
EPS Est.
$0.08
EPS Surpr.
-75.0%
Revenue
$0.60B
Q1 FY2026
Feb 26, 2026Beat
EPS Actual
$0.07
EPS Est.
$0.04
EPS Surpr.
+75.0%
Revenue
$0.54B
Q4 FY2025
Nov 6, 2025Miss
EPS Actual
$0.05
EPS Est.
$0.06
EPS Surpr.
-16.7%
Revenue
$0.58B
Q3 FY2025
Aug 7, 2025Miss
EPS Actual
$0.02
EPS Est.
$0.05
EPS Surpr.
-60.0%
Revenue
$0.52B
Q2 FY2025
May 8, 2025Miss
EPS Actual
$0.03
EPS Est.
$0.06
EPS Surpr.
-50.0%
Revenue
$0.48B
Q1 FY2025
Feb 27, 2025Miss
EPS Actual
$0.03
EPS Est.
$0.05
EPS Surpr.
-40.0%
Revenue
$0.46B
Q4 FY2024
Nov 7, 2024Miss
EPS Actual
$0.03
EPS Est.
$0.05
EPS Surpr.
-40.0%
Revenue
$0.44B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.14 | $0.15 | $0.16 | 5 |
| Q3 FY2028 | $0.18 | $0.19 | $0.20 | 5 |
| Q2 FY2028 | $0.13 | $0.13 | $0.14 | 6 |
| Q1 FY2028 | $0.15 | $0.15 | $0.16 | 3 |
| Q4 FY2027 | $0.11 | $0.11 | $0.12 | 2 |
| Q3 FY2027 | $0.12 | $0.13 | $0.13 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.8B | $0.8B | $0.8B | 6 |
| Q3 FY2028 | $0.8B | $0.8B | $0.8B | 3 |
| Q2 FY2028 | $0.8B | $0.8B | $0.8B | 5 |
| Q1 FY2028 | $0.8B | $0.8B | $0.8B | 3 |
| Q4 FY2027 | $0.6B | $0.7B | $0.7B | 7 |
| Q3 FY2027 | $0.7B | $0.7B | $0.7B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 7, 2026 | -75.0% | $23.99 | $23.99 | +0.00% |
| ▲ Q1 FY2026 | Feb 26, 2026 | +75.0% | $22.65 | $24.91 | +9.98% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -16.7% | $25.02 | $23.98 | -4.16% |
| ▼ Q3 FY2025 | Aug 7, 2025 | -60.0% | $19.78 | $19.51 | -1.37% |
| ▼ Q2 FY2025 | May 8, 2025 | -50.0% | $23.32 | $25.07 | +7.50% |
| ▼ Q1 FY2025 | Feb 27, 2025 | -40.0% | $24.06 | $25.46 | +5.82% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -40.0% | $21.16 | $22.53 | +6.47% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -40.0% | $18.27 | $19.35 | +5.91% |
Q2 FY2026+0.00%
Report Date
May 7, 2026
EPS Beat/Miss
-75.0%
Price Before
$23.99
Price After
$23.99
Q1 FY2026+9.98%
Report Date
Feb 26, 2026
EPS Beat/Miss
+75.0%
Price Before
$22.65
Price After
$24.91
Q4 FY2025-4.16%
Report Date
Nov 6, 2025
EPS Beat/Miss
-16.7%
Price Before
$25.02
Price After
$23.98
Q3 FY2025-1.37%
Report Date
Aug 7, 2025
EPS Beat/Miss
-60.0%
Price Before
$19.78
Price After
$19.51
Q2 FY2025+7.50%
Report Date
May 8, 2025
EPS Beat/Miss
-50.0%
Price Before
$23.32
Price After
$25.07
Q1 FY2025+5.82%
Report Date
Feb 27, 2025
EPS Beat/Miss
-40.0%
Price Before
$24.06
Price After
$25.46
Q4 FY2024+6.47%
Report Date
Nov 7, 2024
EPS Beat/Miss
-40.0%
Price Before
$21.16
Price After
$22.53
Q3 FY2024+5.91%
Report Date
Aug 8, 2024
EPS Beat/Miss
-40.0%
Price Before
$18.27
Price After
$19.35
Avg Beat Reaction+9.98%
Avg Miss Reaction+2.88%
Beat Rate1 / 8 quarters
Largest Move+9.98% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PRVA ends December
Privia Health Group, Inc. (PRVA) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $0.02 — missing the analyst consensus of $0.08 by -75.0%. The next PRVA earnings date is expected around September 1, 2026.
Each quarter, investors track PRVA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PRVA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PRVA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PRVA earnings · 5 questionsPrivia Health Group, Inc.'s next earnings report is expected around September 1, 2026. PRVA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PRVA historically reports after market close (AMC).
PRVA earnings datewhen is PRVA earningsPRVA next earnings datewhen does PRVA report earningsPRVA earnings calendar
▸ Source: FMP · Privia Health Group, Inc. SEC filings · US GAAP · Privia Health Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026